Pill Identifier App

Xeloda Sales Data

Rank 93 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Xeloda U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 93 (2) 6.52% 1.69%
Q3 2013 95 (6) -2.33% -6.35%
Q2 2013 89 (8) 6.87% 6.78%
Q1 2013 97 (2) -2.21% -9.23%
Q4 2012 95 1.16%
Q3 2012 95 (1) 5.28% -1.52%
Q2 2012 96 ()
Q4 2011 96 (5) 1.39%
Q3 2011 91 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
September 17, 2013FDA approves generic drug for advanced cancers
September 17, 2013FDA OKs Generic Xeloda
September 16, 2013First Generic Version of Xeloda Approved
June 9, 2011Chemo for Late-Stage Cancer Patients May Be Unjustified
May 13, 2009Chemotherapy Superior to New Drug for Early Breast Cancer
Hide
(web1)